Search Results 2741-2750 of 19580 for autoimmune hepatitis
Liver (Model for End-Stage Liver Disease (MELD) Score > 20). 2 or more Vasoactive and inotrope medications infusions at time of enrollment: Dobutamine ...
Patients must not have known or suspected autoimmune disease. ... Patients must not have a known history of HIV, hepatitis B, or hepatitis C infection that is ...
Known history of untreated human immunodeficiency virus (HIV)/HIV with a detectable viral load or active hepatitis B or active hepatitis C infection. Any of ...
Current hepatitis B infection (defined as positive for HBsAg and/or total anti-HBc). Participants with immunity to hepatitis B from previous natural ...
Severe non-cardiac morbidity with expected survival of < 6 months (e.g., malignancy, end-stage liver disease, severe chronic lung disease, severe CNS morbidity) ...
Acute or chronic severe liver disease as evidenced by any of the following: encephalopathy, variceal bleeding, INR > 1.7 in the absence of anticoagulation ...
Ongoing, active hepatitis B or C virus infection, or known human immunodeficiency virus (HIV) positive. Liver disease with Child-Pugh class B or C liver ...
Disease known to affect bone integrity (e.g., primary hyperparathyroidism, Pagets disease, clinically significant liver disease). Illicit drug use or ...
Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by ...
El-Masry M, Puig CA, Saab S. Recurrence of non-viral liver disease after orthotopic liver transplantation. Liver Int. 2011 Mar; 31: (3)291-302. View PubMed.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.